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Identification of polymorphism in ethylone
hydrochloride: synthesis and characterization
Chad R. Maheux,a* Idralyn Q. Alarcon,a Catherine R. Copeland,a
T. Stanley Cameron,b Anthony Lindenc and J. Stuart Grossertb
Ethylone, a synthetic cathinonewith psychoactive properties, is a designer drugwhich has appeared on the recreational drugmar-
ket in recent years. Since 2012, illicit shipments of ethylone hydrochloride have been intercepted with increasing frequency at the
Canadian border. Analysis has revealed that ethylone hydrochloride exists as two distinct polymorphs. In addition, several minor
impurities were detected in some seized exhibits. In this study, the two conformational polymorphs of ethylone hydrochloride
have been synthesized and fully characterized by FTIR, FT-Raman, powder XRD, GC-MS, ESI-MS/MS and NMR (13C CPMAS, 1H,
13C). The two polymorphs can be distinguished by vibrational spectroscopy, solid-state nuclear magnetic resonance spectroscopy
and X-ray diffraction. The FTIR data are applied to the identification of both polymorphs of ethylone hydrochloride (mixed
with methylone hydrochloride) in a laboratory submission labelled as ’Ocean Snow Ultra’. The data presented in this study will
assist forensic scientists in the differentiation of the two ethylone hydrochloride polymorphs. This report, alongside our
recent article on the single crystal X-ray structure of a second polymorph of this synthetic cathinone, is the first to confirm
polymorphism in ethylone hydrochloride. © 2015 Canada Border Services Agency. Drug Testing and Analysis published by John
Wiley & Sons, Ltd.
Additional supporting information may be found in the online version of this article at the publisher’s web site.
Keywords: ethylone; polymorphism; synthetic cathinones; designer drugs; new psychoactive substances
Introduction
Ethylone [also called 3’,4’-methylenedioxy-N-ethylcathinone, βk-
MDEA and 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one] 1
joins an ever increasing number of new psychoactive substances
that aremore specifically defined as synthetic cathinones. Synthetic
cathinones are designer drugs that often serve as a replacement
for 3’,4’-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) 2,
other amphetamines and cocaine.[1] These designer drugs are
analogues, derivatives and isomers of cathinone 3 (Figure 1), a
central nervous stimulant found in leaves of the ‘khat’ bush
(Catha edulis).[2] Recently, ethylone has been identified in death
investigations.[3,4]
In Canada, ethylone is controlled as an amphetamine analogue
under the Controlled Drugs and Substances Act. Ethylone was first
seized entering Canada in 2012 and since then, the Canada
Border Services Agency has seized over 100 different shipments
containing this particular designer drug. With all of the modes
(air, land, marine, rail, and postal) available to import commodities
into Canada, ethylone has only been intercepted to date upon
arrival by air and by post. Most ethylone shipments intercepted
at the border arrived by international mail, while the remaining
arrived in Canada by international air courier service. The majority
of these shipments entered Canada in either Ontario or British
Columbia; however, a significant 10 kg shipment of ethylone
was intercepted in Alberta. Shipments of ethylone had various
declarations or labelling (Table 1) and were of different sizes
ranging from several grams to 10 kg, with an average mass of
1 kg. Some shipments were concealed within other objects,
including flashlights and speakers. All shipments to date origi-
nated from China as high purity crystals, except for one packaged
product (labelled as ‘Ocean Snow Ultra’) from Spain that was a
powder mixture of ethylone, methylone, and other minor
ingredients.
Racemic ethylone was patented in 1996 as an anti-depressant [5]
and some analytical data were published shortly thereafter in an
effort to identify this compound rapidly should it appear in the
underground drug market.[6] The mass spectra and nuclear mag-
netic resonance (NMR) spectra of ethylone hydrochloride seized
in Canada were consistent with the literature; however, the infrared
spectra of these exhibits were not the same as previously published
spectra for ethylone hydrochloride.[6–8] The seized exhibits were
found to be racemic, but there remained various possible explana-
tions for the differences in the vibrational spectra. This paper dem-
onstrates that these differences are due to different polymorphic
forms of ethylone hydrochloride. To the best of our knowledge, this
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paper and our related study[9] are the first to describe polymor-
phism in ethylone hydrochloride.
This paper documents the analytical data (Fourier transform in-
frared spectroscopy (FTIR), FT-Raman, X-ray powder diffraction
(XRD), solid-state 13C cross polarization magic angle spinning
nuclear magnetic resonance (13C CPMAS NMR), 1H NMR, 13C NMR,
electrospray ionization-high resolution mass spectra (ESI-HRMS),
liquid chromatography-mass spectrometry (LC/MSn) and gas
chromatography-mass spectrometry (GC-MS)) for two polymorphic
forms of 1 hydrochloride, designated as 1A and 1B. Such data can
be applied to forensic analyses of illicit drug samples. High-
purity reference materials for each polymorph were prepared.
Detailed single-crystal X-ray diffraction data on the reference
materials provided confirmation of the structure of polymorph
1A (space group P212121)
[9] and polymorph 1B (space group
P21/c). The structure of 1B was consistent with previously re-
ported data determined from seized material.[10] The structures
of the cations differ primarily by a 180° rotation about the C–C
bond linking the carbonyl group and side chain to the phenyl
ring (Figure 2). These two conformations are the two distinct
energy minima[9] for this rotation and it is unlikely that any fur-
ther polymorphic forms will be observed that are the result of
the rotation about this C-C bond. This leads to different pack-
ing arrangements, and inversion twinning in 1A, although the
strongest intermolecular interactions in each structure involve
the same · · · Cl · · · H–N–H · · · Cl · · · hydrogen bonding motifs,
which link the cations and anions alternately into extended
chains.[9] In the solid state, 1A and 1B do not interconvert at
room temperature, nor down to 100 K,[9] and as a result, can
be differentiated by vibrational spectroscopy, solid-state nu-
clear magnetic resonance spectroscopy and X-ray diffraction.
A case study is presented in which infrared spectroscopy was
used to identify both polymorphic forms of 1 hydrochloride in a
seized exhibit of Ocean Snow Ultra. In addition, an analysis of sev-
eral seized exhibits revealed 3’,4’-methylenedioxypropiophenone
4 and 3’,4’-methylenedioxy-1,2-propanedione as either synthetic
impurities or as decomposition products.
Experimental procedures
Chemicals, reagents, and methods
All solvents and reagents were purchased from Sigma-Aldrich
(Milwaukee, WI, USA), used without purification and were
analytical grade. Sample solutions for analysis by NMR spectros-
copy were prepared with 99.9% D anhydrous CD3OD from 1mL
ampoules.
Instrumentation
Density Functional Theory Computations were carried out as
described previously.[9] The computed atomic coordinates of 1A
and 1B are provided in the Supporting Information.
For X-ray fluorescence spectrometry (Fischerscope X-ray XAN-
DPP with WINFTM EDXRF software), samples were placed directly
on a polypropylene X-ray TF-250 thin film and analyzed with an
energy of 50 kV and a collimator diameter of 0.6mm.
Images of crystalline polymorphs 1A and 1B were recorded
using a Keyence Digital Microscope VHX-600E (with VH-Z00R and
VH-Z100UR lenses) with suitable magnifications.
Melting point temperatures were determined in open capillaries
on a Mettler Toledo FP900 Melting Point System and are uncor-
rected. Samples were heated from 180 °C at a constant heating rate
of 1 °C/min.
Differential scanning calorimetry (DSC) analyses were performed
by Integrity Testing Laboratory Inc., using a TA Instruments DSC
Q10 calorimeter. Prior to the analysis, the DSC was calibrated
using an indium calibration standard having a melting point of
156.60 °C and enthalpy of fusion 28.45 J/g. Each polymorph
(10mg) was placed in sealed aluminum pans and heated from
25 °C to 300 °C at a scanning rate of 10 °C/min under a nitrogen
atmosphere (50mL/min), followed by a dwell time of 5min. Cooling
was performed at 10 °C/min from 300 °C to 25 °C, followed by a
dwell time of 5min. A second heating was run under the same
conditions as the first heating. DSC data are provided in the
Supporting Information.
Thermogravimetric analyses (TGA) were determined using a
Shimadzu TGA-50 thermogravimetric analyzer. The apparatus was
calibrated with calcium oxalate monohydrate. Polymorphs 1A
Figure 1. Chemical structures of ethylone 1, MDMA 2 and cathinone 3.
Table 1. Various Customs declarations or labelling for shipments found
to contain 1 hydrochloride
Ocean Snow Ultra Acrylic paint Facial mask powder
Iron Oxide Black Sodium isethionate Mandy Brown
Zeolite Food materials Salt rock
Geolite Phenolic resin Gelatin
Figure 2. The molecular structures of polymorphs 1A (left) and 1B (right) from the single crystal structure determinations, showing the different
conformations of the cationic fused ring system relative to the alkyl chain.
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(7.542mg) and 1B (10.020mg) were each heated on platinum pans
from 25 °C to 1000 °C at a rate of 10 °C/min. The samples weremain-
tained under a nitrogen atmosphere (20mL/min) until 650 °C, when
the atmosphere was switched to air. TGA data are provided in the
Supporting Information.
ATR-FTIR spectra were recorded on a Nicolet iS50 FTIR, with a sin-
gle reflection diamond ATR accessory. Range: 4000 – 650 cm-1, 16
scans and 4 cm-1 resolution. Raman spectroscopy was performed
using a Nicolet 6700 FTIR with an NXR FT-Raman module on sam-
ples in an NMR tube with an excitation laser power of 1.0W and
an InGaAs detector. Range: 4000–100 cm-1 Raman shift, 128 scans,
1064 nm Nd-YVO4 excitation laser.
The powder X-ray diffraction (XRD) patterns were collected on a
PANalytical X’Pert-PRO diffractometer using Cu Kα1 radiation
(λ =1.54060Å) at 45 kV, 40mA with programmable divergence
and anti-scatter slits in automatic mode with an irradiated and
observed length of 8.0mm. A fixed 2° anti-scatter slit was used in
the incident beam. Each sample was back-loaded into a
PW1172/01 aluminum sample holder. Samples were analyzed in
continuous mode with a step size of 0.017° and scan rate of 0.1°/s
over an angular range of 5–70° 2θ. Data were collected at room
temperature.
Solid-state 13C CPMAS NMR spectra were collected on each poly-
morph using a Bruker AVANCE 500MHz NMR spectrometer at the
University of Ottawa NMR Facility. Approximately 60mg of each
polymorph was packed in a 4mm zirconia rotor equipped with a
kel-F cap. The samples were spun at 10 kHz in a 4mm Bruker
CPMAS probe. Data were collected using a cross polarization pulse
sequence using a ramped 1H contact pulse and high power SPINAL
64 decoupling. The 1H 90° pulse, contact time, recycle delay, and
acquisition time were 2.5μs, 2ms, 4 s, and 32.6ms, respectively.
The spectra were the result of 512 scans. The data were zero-filled
to 16K data points and processed with 10Hz of exponential line
broadening. The chemical shifts are reported with respect to the
carbonyl carbon chemical shift of solid glycine, which was taken
to be 176.5 ppm with respect to TMS at 0 ppm.
1H and 13C solution-state NMR spectra were recorded at 298K in
5mm NMR tubes in CD3OD on a Bruker AVANCE III 400 spectrome-
ter at 400.13MHz (1H NMR) or 100.62MHz (13C NMR). Chemical
shifts are given in parts per million (ppm) relative to the solvent sig-
nal of δ=3.31 ppm for 1H NMR spectroscopy and δ=49.00ppm for
13C NMR spectroscopy. Coupling constants (J) are expressed in
Hertz (Hz). The following abbreviations are used to designate
NMR absorption patterns: s, singlet; d, doublet; dd, doublet of dou-
blets; app t, apparent triplet; q, quartet. The spectra are found in the
Supporting Information.
Accurate mass HRMS were obtained on a Thermo Scientific LTQ
Orbitrap XL mass spectrometer by flow injection (with an eluent
of 0.1% formic acid in 50:50 methanol/water) using ESI. The
instrument was operated in positive mode with a resolution setting
of 30 000 (FWHM) atm/z 400 and internal lock masses of 391.28429
for the [M+H]+ ion of dioctyl phthalate and 338.34174 for the [M
+H]+ ion of erucamide. Data were acquired in full-scan mode over
a range of m/z 100–1000 in the Orbitrap and in product ion (MSn)
mode in ranges between m/z 50 and 250 in both the Orbitrap
and linear ion trap (IT). Collision-induced dissociations were carried
out at normalized collision energies of 25% for MS2 or 35% for all
other MSn experiments.
GC-MS data were collected using an Agilent 7890A GC with
autosampler 7693 series, 1μL injection, at various split ratios,
4mm single gooseneck liner (deactivated, with glass wool), DB5MS
column (30m×0.25mm×0.25μm) with constant flow (1mL/min
of helium) coupled to an Agilent 5975C with a Triple-Axis Detector.
Electron ionization (EI) operating parameters were: inlet tempera-
ture 280 °C, interface temperature 280 °C, MS source temperature
230 °C, MS Quad temperature 150 °C, 70 eV ionization energy. The
oven temperature program started at an initial temperature of
100 °C with a ramp of 10 °C/min to 300 °C. The final temperature
was held for 25min (total run time 45min).
Synthetic procedures
The synthetic pathway used to prepare 1A and 1B is given in
Scheme 1. This synthetic route is commonly used for the synthesis
of most cathinone analogues.[11] Starting material 4 was treated with
bromine to form the α-brominated precursor 5 in quantitative yield.
Subsequent reaction of 5 with ethylamine in tetrahydrofuran pro-
duced 1. After work-up, polymorph 1A was formed when 1 was
treated with ethereal hydrogen chloride, whereas polymorph 1B
was formed when 1 was treated with methanolic hydrogen chloride
and left to crystallize. Polymorphs 1A and 1B were each collected in
high yields as a finewhite powder or as colourless crystals respectively.
Results and discussion
Synthesis of reference materials and identification of impuri-
ties from seized exhibits
Several synthetic routes have been used and proposed for the
preparation of cathinones.[12–14] Seized exhibits containing 1 hy-
drochloride were also analyzed to determine whether impurities
may be characteristic of a manufacturing route.
Scheme 1. Synthetic pathway used to prepare 1A and 1B.
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When seized exhibits of 1 hydrochloride were first analyzed,
X-ray fluorescence (XRF) was used to obtain an elemental profile.
In the first few seized exhibits, bromine and chlorine were
detected. Bromine was also detected by XRF in selected exhibits
of cathinone analogues purchased from ‘smart shops’ in
Portugal.[15] Synthetic cathinone analogues are traditionally pre-
pared as hydrochloride salts but have been reported as pure
hydrobromide salts[10,16] and as mixed bromide/chloride
salts.[10,17] Given that the NMR and GC-MS data of the seized
exhibits were consistent with a chemical structure of 1, it was
possible that ethylone was prepared as a hydrobromide salt,
hydrochloride salt, or as a mixed bromide/chloride salt. Reference
materials of 1 hydrochloride were synthesized and a comparison
of vibrational spectroscopic (FTIR, FT-Raman) and X-ray diffraction
(powder and single-crystal) data to those obtained from seized
exhibits was used to confirm that the seized exhibits were also
hydrochloride salts. As a result, this conclusion suggested that
any detected bromine was present as an artifact of the synthetic
route which likely proceeds via the formation of the α-brominated
precursor 5.
Two other minor impurities were detected in seized exhibits,
namely, 4 and 3’,4’-methylenedioxyphenyl-1,2-propanedione. The
identification of 4 was confirmed by ESI-HRMS and GC-MS. The
presence of 4 could represent either a synthetic precursor for, or
a decomposition product of, 1 or 1 hydrochloride.
The other impurity, 3’,4’-methylenedioxyphenyl-1,2-propanedione,
was identified by GC-MS. A related dione was identified as a
decomposition product in diethylpropion hydrochloride.[18] Also,
cathinone can readily be oxidized in vitro to 1-phenyl-1,2-
propanedione.[19] Therefore, it was postulated that 3’,4’-
methylenedioxyphenyl-1,2-propanedione is also a decomposition
product of 1. It has been reported that cathinone derivatives are
unstable, for example, with varying pH,[20] with applied
heat,[18,21,22] and in air.[23] As a result, a limited study was con-
ducted on the stability of 1 hydrochloride under various condi-
tions. It was found by GC-MS analysis that 4 and 3’,4’-
methylenedioxyphenyl-1,2-propanedione are formed from 1 hy-
drochloride in all of our experiments. Under acidic conditions, 4
and 3’,4’-methylenedioxyphenyl-1,2-propanedione were the
main decomposition products, while under alkaline conditions,
many other additional products were observed. The application
of heat (at slightly elevated temperature or pyrolysis) to solid 1
hydrochloride also resulted in the formation of 4 and 3’,4’-
methylenedioxyphenyl-1,2-propanedione and other products.
Pyrolysis results in many other byproducts, including suspected
iso-ethylone with a base peak of m/z 178 in the mass spectrum.
The application of both heat and humidity resulted in an increase
in the relative ratio of ketone to dione when compared to the re-
sults from the other experiments. In air at ambient conditions, 4
and 3’,4’-methylenedioxyphenyl-1,2-propanedione were also
identified with time as the main decomposition products albeit
in low concentrations. Starting material 1A was analyzed by
GC/MS to be of high purity before being subjected to these vary-
ing conditions.
These preliminary studies can only be used to support rather
than confirm that a synthetic route, such as the one presented in
Scheme 1, is being used for the illicit preparation of 1A and 1B.
The precursor 4 may be the starting material in seized exhibits, or
it is possible that 4 was prepared from other chemicals, including
isosafrole[24] or piperonal.[25] Seized exhibits of 1 hydrochloride
were found to be racemic, which supports the synthetic route in
Scheme 1. Additional work would be needed to confirm the syn-
thetic route and to identify the chemicals used to prepare 1A and
1B in seized exhibits, but this would likely be necessary for each in-
dividual exhibit.
To test the synthetic route presented in Scheme 1, the hydro-
chloride salt of 1 was successfully synthesized from the precursor
4. As discussed in the Synthetic Procedures, polymorph 1A
was formed when the free base 1 was treated with ethereal
hydrogen chloride, whereas polymorph 1B was formed when the
free base 1 was treated with methanolic hydrogen chloride and
left to crystallize. Polymorph 1A was also found to persist when
the salt was recrystallized from 50:50 v/v methanol-water at
temperatures above 308 K,[9] whereas repeated recrystallization
from such a solution at room temperature ultimately yielded
polymorph 1B.
Characterization of polymorphs
The two crystalline forms of 1 hydrochloride have significantly dif-
ferentmorphology. While 1A appears as very small fine needle crys-
tals, 1B exists as large block-shaped crystals (Figure 3).
Melting points for 1A are reported as 225–228 °C [6] and 236–
243 °C; [8] however, the thermal analyses (melting point determina-
tion, DSC and TGA) indicate that 1A and 1B show no endothermic
melting point before decomposition. This feature is not uncommon
Figure 3. Keyence images of recrystallized 1A (left) and 1B (right).
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for alkylammonium hydrochloride salts.[26,27] During the melting
point determination, the product decomposes to a dark brownma-
terial rather than melting and the values obtained (220–230 °C)
were not reproducible. In the DSC experiments, it was found that
each polymorph exhibited a single endothermic transition at
256 °C; however, this transition does not seem to be related to a
melting endotherm since no other transitions were detected in
the cooling and second heating runs for each sample. Overall, it
was not possible to separate melting from decomposition with
these techniques. The results from TGA further support decomposi-
tion as the thermal curves for each polymorph are similar to the
thermal curve of the decomposition of dipropylammonium
chloride.[27] Due to the decomposition of 1A and 1B during heating
and the lack of reproducibility in the melting points determined,
the melting point cannot be used as a characteristic physical prop-
erty for these compounds.
When either 1A or 1B is dissolved in solvent, the analytical data
from the GC-MS, LC-MS, and NMR are identical. When either 1A
or 1B is dissolved in methanol and quickly evaporated to dryness,
1A is obtained. This is consistent with our hypothesis that the (A)
conformer is more stable in solution.[9] From 1A, it is possible to
form 1B through a recrystallization process; however, it is more re-
producible to proceed by treating the free base 1 with methanolic
hydrogen chloride. Most experiments resulted in a mixture of both
forms.
Vibrational spectroscopy: infrared and FT-Raman spectra
Vibrational spectroscopy is well-suited to characterizing small
organic molecules, including cathinones. Infrared spectroscopy
has been used to distinguish cathinone homologues[6,7,12] and to
differentiate cathinone regioisomers.[28,29] Similarly, Raman spec-
troscopy has been used for the identification and characterization
of cathinones[30] and their mono-substituted and methylenedioxy
substituted regioisomers.[31] Although vibrational spectroscopy
has long been applied to the study of polymorphs, particularly
for the purposes of the pharmaceutical industry, to our knowl-
edge, this is the first published report of infrared and Raman spec-
troscopy being used to differentiate polymorphs of the same
cathinone.
The ATR-FTIR spectra (Figure 4) of 1A and 1B are significantly
different as a consequence of the molecular conformational dif-
ferences within the crystal structure of each polymorph. The
ATR-FTIR spectrum of 1A is consistent with previously published
spectra for synthesized ethylone hydrochloride.[6–8] However, the
ATR-FTIR spectrum of 1B has not been published and is discussed
here for the first time in comparison with the spectrum of 1A.
Both spectra show the characteristic bands associated with the
hydrochloride salts of methylenedioxy substituted cathinones.
These typically include a broad pattern from about 2200–
3100 cm-1 corresponding to a combination of C-H stretches and
Figure 4. ATR-FTIR spectra of 1A and 1B.
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absorption bands from the amine salt, an absorbance in the
1660–1690 cm-1 region for the carbonyl group in conjugation
with the methylenedioxyphenyl group, aromatic C=C ring vibra-
tion bands in the region of 1600–1625 cm-1 and a strong C-O
stretching vibration from the methylenedioxy group at approxi-
mately 1250 cm-1. The bands below 1500 cm-1 generally allow
for unambiguous identification of cathinones.
One of the key features of the infrared spectra of cathinones is
the absorbance of the carbonyl group and one significant differ-
ence in the IR spectra of these two polymorphs is the frequency
of the carbonyl band, which absorbs at approximately 1673 cm-1
for 1A and 1687 cm-1 for 1B.
These spectra were recorded in the solid phase and thus reflect
differences between the crystal structures of 1A and 1B. The dif-
ferences in the carbonyl band frequencies arise from different
force constants between the two atoms of the carbonyl groups
which can be caused by electron-density differences, crystal pack-
ing forces or by different C–C–C=O torsion angles between the
aryl ring and the carbonyl group. These torsion angles are 7.9
(8)o for 1A and 21.8(2)o for 1B.[9] A similar effect has been noted
in the shift of the C=O band for 2’-methylmethcathinone rela-
tive to those of the 3’-methylmethcathinone and 4’-
methylmethcathinone isomers.[28]
Nevertheless, the differences in stretching frequencies between
the two carbonyl groups appear to be an intrinsic property of the
two cations, as the computed frequencies for 1A and 1B (gas
phase, 298 K) were 1779 and 1810 cm-1, respectively. Correspond-
ingly, these structures had aryl-carbonyl torsion angles of 3.2o and
12.8o, respectively. Images of these structures are given in the
Supporting Information.
Similar effects may be responsible for a shift of the C=C ring vi-
bration band from 1605 cm-1 in 1A to 1613 cm-1 in 1B. The C=C
band in the 2’,3’-methylenedioxy substituted cathinones was also
shifted to a higher wavenumber when compared to the corre-
sponding 3’,4’-methylenedioxy analogues.[29]
The FT-Raman spectra (Figure 5) of 1A and 1B are also signifi-
cantly different, allowing each polymorph to be unambiguously
identified. As predicted, they have the characteristic Raman shifts
associated with methylenedioxy substituted cathinones, while
exhibiting the differences found in their corresponding infrared
spectra due to the conformation and packing of the crystals. For ex-
ample, the C=O and C=C shifts for 1A are at 1673 and 1607 cm-1,
while those for 1B are found at 1686 and 1613 cm-1, respectively.
Peak lists and expansions of the fingerprint regions of the ATR-
FTIR spectra and FT-Raman spectra of 1A and 1B are provided in
the Supporting Information.
Application to Ocean Snow Ultra exhibit:
In 2012, a seized exhibit consisting of a fine white crystalline
powder in a pouch labelled as Ocean Snow Ultra was received
Figure 5. FT-Raman spectra of 1A and 1B.
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at our laboratory for chemical analysis. Initial screening by ATR-
FTIR suggested the exhibit was composed of more than one
cathinone and other minor ingredients. The powder was identi-
fied as a mixture of methylone and ethylone by GC-MS, GC/-IR
and ESI-MS/MS. Further investigation of the ATR-FTIR spectrum
revealed evidence of both polymorphic forms of 1 hydrochloride
in this exhibit (Figure 6).
Powder X-ray diffraction (XRD)
Powder X-ray diffraction (XRD) is a powerful analytical technique
for the identification of crystalline compounds. A powder diffrac-
tion pattern is produced by the interaction of monochromatic X-
rays with the regular repeating packing arrangement of the
Figure 6. ATR-FTIR spectra (650–2000 cm-1) of Ocean Snow Ultra. Top: Ocean Snow Ultra (blue trace) shown with 1B (red trace). Middle: Ocean Snow Ultra
with 1B subtracted (blue trace) shownwithmethylone hydrochloride (red trace). Bottom: Ocean SnowUltra with 1B andmethylone hydrochloride subtracted
(blue trace) shown with 1A (red trace).
Figure 7. Overlaid measured powder X-ray diffractograms of 1A and 1B.
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molecules within the crystal powder producing the pattern. This
technique is usually non-destructive, can discriminate between
different forms (polymorphs, solvates) of the same compound
and can be used to identify different components in a mixture.
Therefore, powder XRD is widely used in the pharmaceutical in-
dustry and is an emerging technique for the forensic analysis of
controlled drugs. X-ray diffractometry is listed as a Category A
analytical technique by the Scientific Working Group for the Anal-
ysis of Seized Drugs (SWGDRUG).[32]
Since different polymorphic forms of the same substance will
give different XRD patterns,[33,34] this technique was used to con-
firm polymorphism in 1 hydrochloride. The two conformations
have significantly dissimilar shapes (Figure 2) and, therefore, the
packing of the molecules in each polymorph will not be the same.
Thus, the powder diffraction patterns from crystals of each poly-
morph will be characteristically and identifiably different.
The diffractograms for polymorphs 1A and 1B (Figure 7)
show many diagnostic peaks that do not overlap with or are
absent in the other pattern, and hence they can be used for
unambiguous identification of the polymorphs. Based on the
patterns, it is clear that 1A is not present in samples of pure 1B
and vice versa. This also demonstrates that the two polymorphs
do not interchange during preparation (grinding) for the powder
XRD analysis.[9,33,35] Each pattern is reproducible and can be used
as a reference for identification of an unknown sample containing
1 hydrochloride.
To validate the data obtained from powder XRD, patterns of 1A
and 1B were simulated from their single crystal X-ray crystallogra-
phy reflection data measured at room temperature and compared
with the measured powder XRD patterns (Figure 8).
There is a slight difference between the simulated andmeasured
patterns of 1B. This includes the intensity difference due to the pre-
ferred orientation and multiplicity effects.[36] It has been observed
that this distortion can be eliminated using transmission mode in-
stead of reflection mode in the analysis of famotidine.[37]
The simulated and experimental patterns of 1A vary in intensity
and the resolution of the peaks observed. Some peak broadening is
evident in the experimental pattern, possibly as a consequence of
the crystallinity of the measured sample and preferred orientation
of the powdered needles, and overlap of smaller peakswith the larger
peaks is observed around 13°, 16°, 25°, 27°, and 29° in 2θ. The powder
pattern of 1B does not show such significant peak broadening.
Nuclear magnetic resonance (NMR)
Conformational polymorphs are expected to have different solid-
state NMR spectra given that the molecular arrangements in the
crystal are different.[38] The solid-state 13C CPMAS NMR spectra for
1A and 1B are shown in Figure 9. The assignments were made to
correspond to those determined from solution-state NMR (Table 2).
It is clear that the spectra are not identical and the data support that
Figure 8. Simulated andmeasured powder X-ray diffractograms of 1A and
1B.
Figure 9. Solid-state 13C CPMAS NMR spectra of 1A (bottom) and 1B (top).
The smaller peaks marked with an asterisk (*) are spinning sidebands.
Table 2. NMR assignments for 1 hydrochloride
Position Solid-state 13C CPMAS NMR Solution-state NMR (CD3OD)
δ 1A δ 1B δ 13C δ 1H, m, J (Hz)
1 193.98 194.11 195.0 -
2 59.88 59.15 58.9 5.08, 1H, q, 7.2
3 18.87 16.54 16.9 1.57, 3H, d, 7.2
1’, 6’ 127.84 128.50, 127.25 128.7 (C-1’) -
127.2 (C-6’) 7.72, 1H, dd, 1.8, 8.2 (H-6’)
2’, 5’ 108.63, 106.05 110.59, 109.36 109.0 (C-2’) 7.50, 1H, d, 1.8 (H-2’)
109.5 (C-5’) 7.01, 1H, d, 8.2 (H-5’)
3’ 149.26 149.00 150.3 -
4’ 153.16 153.03 155.0 -
7’ 102.61 103.24 104.0 6.12, 2H, s
1” 42.77 42.54 42.4 3.11, 2H, ABX3, 7.3, 12.3
2” 13.30 10.55 11.7 1.37, 3H, app t, 7.3
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1A and 1B are separate solid polymorphs of 1 hydrochloride. The
resonances for 1A are 2 to 3 times broader than those for 1B sug-
gesting that 1A is less crystalline than 1B.
A combination of 1D (1H, 13C, 13C-DEPT) and 2D (COSY, 1H,13C-
HSQC, 1H,13C-HMBC) NMR experiments for 1 hydrochloride in
CD3OD permitted the unambiguous assignment of all carbon and
hydrogen resonances. The 1H and 13C NMR spectra are presented
in the Supporting Information and are generally consistent with
previously reported data in the same solvent.[7]
The N-ethyl moiety gives 1 hydrochloride an interesting signal
pattern in the 1H NMR. The diastereotopic methylene protons,
coupled to one another and to themethyl protons (H-2”), show sec-
ond order effects. Each proton of the methylene group exhibits
geminal coupling (J=12.3Hz) and further vicinal coupling
(J=7.3Hz). As a result, this spin system is described as an ABX3
and is consistent with the signals from the N-ethyl group in 4’-
methyl-N-ethylcathinone.[39] The methyl protons (H-2”) of the N-
ethyl group are equally coupled to each of the non-equivalent
methylene protons and appear as an apparent triplet (J=7.3Hz)
at 1.37 ppm. The doublet of triplets reported in the literature [7]
for this signal was not observed.
Liquid chromatography-mass spectrometry and high resolu-
tion mass spectrometry
The accurate mass ESI-HRMS data obtained for 1 hydrochloride are
consistent with the chemical formula of ethylone. The mass accura-
cies of the protonated molecule (C12H16NO3
+, m/z 222.11252) and
the related isotope peak (C11
13CH16NO3
+, m/z 223.11584) experi-
mentally determined on 1A, were well within 1 ppm.
Fragmentation data were obtained from selected precursor ions
by collision-induced dissociation in the linear ion trap with the
resulting product ions detected in the ion trap (Figure 10) and in
the Orbitrap (Table 3).
The fragmentation pathways for cathinones under the condi-
tions used in ESI-HRMS instruments are distinctly different from
those observed in EI-MS spectra. It does not appear that a formal
study of the fragmentation mechanisms of cathinones, including
ethylone, has been completed, however, the origins of many of
the characteristic fragments have been proposed.[40–46]
Figure 10. Product ion spectra on a linear ion trap for 1: MS2 on m/z 222 (top); MS3 on m/z 222, 204 (middle); and MS3 on m/z 222, 174 (bottom).
Table 3. Proposed assignment of the primary fragments from the
product ion spectra of 1
MSn Selected
precursor
ion (m/z)
Product
ion (m/z)
Mass
accuracy
(ppm)
Proposed
Formula
Proposed source
of fragment from
precursor ion
MS2 222.11 204.10185 -0.26 C12H14NO2
+ loss of water
177.05457 -0.31 C10H9O3
+ loss of
ethylamine
174.09132 -0.10 C11H12NO
+ loss of CH2O
72.08064 -1.95 C4H10N
+ iminium ion
MS3 204.10 174.09129 -0.27 C11H12NO
+ loss of CH2O
MS3 174.09 159.06790 +0.22 C10H9NO
+• loss of methyl
radical
146.09643 +0.01 C10H12N
+ loss of CO
131.07290 -0.38 C9H9N
+• loss of methyl
radical
(subsequent
to loss of CO)
MS5* 146.10 131.07296 +0.09 C9H9N
+• loss of methyl
radical
* same result obtained by either MS4 or MS5
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The primary fragments in the ESI-HRMS of 1 are consistent with
the neutral loss of water ([M+H-H2O]
+, m/z 204), subsequent loss
of formaldehyde ([M+H-H2O-CH2O]
+, m/z 174) and subsequent
loss of CO ([M+H-H2O-CH2O-CO]
+, m/z 146). The m/z 174 ion has
also been postulated[41] to form by loss of the methylenedioxy
moiety from the parent ion, [M+H-CH2(OH)2]
+, and while this
pathway has not been ruled out, our MS2 data suggests that it is
forming from the dehydrated species. Other ions observed in the
product ion spectra include m/z 177 (loss of ethylamine), m/z 159
(loss of a methyl radical from m/z 174), m/z 131 (loss of a methyl
radical from m/z 146) and m/z 72 (the iminium ion formed from
the side chain). No significant amount of the acylium ion at m/z
149 was observed in our experiments. Isotopic labelling studies
are required to provide a complete mechanism of the fragmenta-
tion pathways.
Gas chromatography-mass spectrometry
The EI-MS is shown in Figure 11 and is consistent with previously
reported data.[7,8] Consistent with other synthetic cathinones, the
molecular ion (m/z 221) is weak and the base peak (m/z 72)
corresponds to the formation of an iminium ion (C4H10N
+).
Conclusion
This work describes and provides analytical data for two poly-
morphic forms of the designer drug ethylone hydrochloride to
assist forensic chemists in their identification. The two poly-
morphs of ethylone hydrochloride were synthesized in our
laboratory and it has been shown that they can be distin-
guished easily by ATR-FTIR, FT-Raman, powder XRD, and solid-
state NMR. The synthesized ethylone was also characterized
by GC-MS, ESI-HRMS and solution-state NMR. The analytical data
have been used to identify ethylone hydrochloride in seizures
made by the Canada Border Services Agency. All seizures to
date have been in form 1B, other than one exhibit of Ocean
Snow Ultra that was shown to contain both polymorphs. It
has been found that each polymorph of ethylone hydrochloride
can be converted under appropriate conditions into the other
form for comparison to reference spectra. This approach may
also apply if polymorphs of other synthetic cathinones are
encountered.
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